Wells Fargo & Company Compugen LTD Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Compugen LTD stock. As of the latest transaction made, Wells Fargo & Company holds 45,900 shares of CGEN stock, worth $75,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,900

Previous 42,900 6.99%

Holding current value

$75,276

Previous $110,000 30.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.68 - $2.52 $5,040 - $7,560	3,000 Added 6.99%	45,900 $77,000
Q1 2024 May 10, 2024	BUY	$1.75 - $2.95 $64,225 - $108,265	36,700 Added 591.94%	42,900 $110,000
Q4 2023 Feb 09, 2024	BUY	$0.53 - $2.0 $318 - $1,200	600 Added 10.71%	6,200 $12,000
Q1 2023 May 12, 2023	SELL	$0.68 - $1.11 $680 - $1,110	-1,000 Reduced 15.15%	5,600 $3,000
Q4 2022 Feb 13, 2023	BUY	$0.58 - $1.2 $290 - $600	500 Added 8.2%	6,600 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.66 - $2.32 $1,320 - $4,640	-2,000 Reduced 24.69%	6,100 $5,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $3,824 - $6,694	-935 Reduced 10.35%	8,100 $35,000
Q3 2021 Nov 15, 2021	SELL	$5.8 - $8.02 $5,800 - $8,020	-1,000 Reduced 9.97%	9,035 $54,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $59,233 - $78,977	-8,622 Reduced 46.21%	10,035 $83,000
Q1 2021 May 13, 2021	BUY	$7.67 - $13.77 $83,610 - $150,106	10,901 Added 140.55%	18,657 $160,000
Q4 2020 Feb 09, 2021	BUY	$12.07 - $17.95 $37,742 - $56,129	3,127 Added 67.55%	7,756 $94,000
Q3 2020 Nov 05, 2020	SELL	$14.16 - $19.45 $498,304 - $684,464	-35,191 Reduced 88.38%	4,629 $76,000
Q2 2020 Aug 13, 2020	BUY	$6.97 - $17.12 $68,898 - $169,231	9,885 Added 33.02%	39,820 $599,000
Q1 2020 May 14, 2020	BUY	$5.79 - $11.83 $173,323 - $354,131	29,935 New	29,935 $217,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.3M

Call Options Held

191K

Put Options Held

135K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Compugen LTD Transaction History